C M Segeren

Summary

Country: The Netherlands

Publications

  1. ncbi Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma
    C M Segeren
    University Hospital Rotterdam and University Hospital Utrecht for the Belgium Dutch Haematology Oncology Group HOVON, The Netherlands
    Br J Haematol 105:127-30. 1999

Detail Information

Publications1

  1. ncbi Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma
    C M Segeren
    University Hospital Rotterdam and University Hospital Utrecht for the Belgium Dutch Haematology Oncology Group HOVON, The Netherlands
    Br J Haematol 105:127-30. 1999
    ..VAD administered as an outpatient regimen, based on rapid intravenous infusion, is an effective induction regimen for untreated myeloma with a 67% response rate and acceptable toxicity...